Outcome of Board Meeting

Date: October 30, 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544886 NSE Scrip Symbol: TEMPSENS Subject: Outcome of Board Meeting held on October 30, 2026 Dear Sir / Madam, Pursuant to Regulations 30 and other applicable provisions of the SEBI Listing Regulations, we hereby inform you that the Board of Directors of the Company at its meeting held today i.e., Friday, October 30, 2026, inter alia, approved the following: Unaudited financial results both standalone and Consolidated for the Quarter and half year ended September 30, 2026 along with Limited Review Report of Statutory Auditor of the Company- Annexure 1. A. Appointment of Mr. Aryan Rathi as an Additional Director of the Company, designated as ExecutiveDirector cum Lead-Global Sales, for a period of 5 (five) consecutive years i.e., 2. (DIN-11607932) from October 30, 2026,subject to approval of the shareholders. Consequent to his appointment as Executive Director with effect from October 30, 2026, Mr. Aryan Rathi will continue to oversee the Company's Global Sales function. However, he will cease to be classified as Senior Management Personnel with effect from the same date. This change is consequential to his appointment as Director and does not constitute cessation of his employment or functional responsibilities relating to Global Sales. Details are given in Annexure B. Accepted the resignation of Mr. Ankit Talesra from the position of Non- Executive Director of theCompany with effect from October 30, 2026. Details are given in Annexure 3. B.A copy of the resignation letter is enclosed. (DIN-02709075) Ap pointment of M/s P C MODI & CO (Firm Registration No. 000239C) as Joint Statutory Auditor of the Company, in accordance with Section 139 of the Companies Act, 2013 and the rules made 4. thereunder, to hold office until the conclusion of the ensuing Annual General Meeting, subject to the approval of the shareholders by way of Postal Ballot. Details are given in Annexure B. Ratification of the Tempsens Instrument Employees Stock Option Plan 2025 ("ESOP 2025") 5. Ratification in extension of benefits of the Tempsens Instruments Employees Stock Option Plan 2025 to the eligible employees of the Group Company including Subsidiary Company, Associate Company, 6. in India or outside India and Holding Company. Details are given in Annexure C. Based on the recommendation of the Nomination and Remuneration Committee, the Board approved the ratification of ESOP 2025 in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ("SBEB Regulations"), subject to approval of the shareholders by way of Postal Ballot. The ratification is sought in terms of Regulation 12(1) of the SBEB Regulations, the scheme having been formulated prior to the Company's initial public offering, and also pursuant to Section 62(1)(b) of the Companies Act, 2013 read with Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014. 7. Appointment of M/s. Ronak Jhuthawat & Co., Practising Company Secretaries, as the Scrutinizer for scrutinizing the remote e-voting process in respect of the resolutions proposed to be passed through Postal Ballot, in a fair and transparent manner. 8. Approved the issuance of the Postal Ballot Notice to the Members of the Company for seeking their consent on the resolutions proposed to be passed through Postal Ballot by way of remote e-voting, in accordance with the applicable provisions of the Companies Act, 2013 and the rules made thereunder. The meeting of the Board of Directors commenced at 03:00 P.M. and concluded at 07.00 P.M Kindly take the above intimation on record. Thanking you, Yours Truly, For Tempsens Instruments (India) Limited Name: Vishal Jain Designation: Company Secretary Cum Compliance Officer Membership No: A45820 Independent Auditor’s Review Report on Consolidated Unaudited Quarterly Financial Results and Year to Date Results of Tempsens Instruments (India) Limited (formerly known as Tempsens Instruments (India) Private Limited) pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Tempsens Instruments (India) Limited (formerly known as Tempsens Instruments (India) Private Limited) 1. We have reviewed the accompanying statement of consolidated unaudited financial results (‘the Statement’) of Tempsens Instruments (India) Limited (formerly known as Tempsens Instruments (India) Private Limited) (‘the Holding Company’) and its subsidiaries (the Holding Company and its subsidiaries together referred to as ‘the Group’), and its joint ventures (refer Annexure 1 for the list of subsidiaries and joint ventures included in the Statement) for the quarter ended 30 September 2026 and the consolidated year to date results for the period 01 April 2026 to 30 September 2026, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’). Attention is drawn to the fact that the corresponding quarter ended 30 September 2025 and the corresponding period from 01 April 2025 to 30 September 2025, as reported in the Statement have been approved by the Holding Company’s Board of Directors but have not been subjected to audit or review. 2. This Statement, which is the responsibility of the Holding Company’s management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33 (8) of the Listing Regulations, to the extent applicable. Independent Auditor’s Review Report on Consolidated Unaudited Quarterly Financial Results and Year to Date Results of Tempsens Instruments (India) Limited (formerly known as Tempsens Instruments (India) Private Limited) pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (cont’d) 4. Based on our review conducted and procedures performed as stated in paragraph 3 above and upon consideration of the review reports of the other auditors referred to in paragraph 5 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information requ [Showing first 8,000 characters — download PDF for full document]